XNAS: AVTX
Avalo Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Avalo Therapeutics Inc is a clinical stage biotechnology company fully dedicated to developing IL-1B-based treatments for immune-mediated inflammatory diseases. The company's asset is Abdakibart (AVTX-009) an anti-IL-1B monoclonal antibody ("mAb"), t...
Read More
19.01
-0.84
(-4.23%)
1.7M
XNAS Volume
XNAS 14 May, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Avalo Therapeutics Inc is on 19 May 2026 for the purpose of Avalo Therapeutics Inc First Quarter Earnings Results for 2026
See details
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Avalo Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..